Cent Eur J Public Health 2016, 24(2):95-102 | DOI: 10.21101/cejph.a4007

Waist Circumference-to-Height Ratio Detected in a Convenient Sample of Young Slovak People with Increased Cardio-Metabolic Risk

Zdenka Hertelyová1, Janka Va¹ková2, Ladislav Va¹ko2
1 Department of Experimental Medicine, Faculty of Medicine, Pavol Jozef ©afárik University in Ko¹ice, Ko¹ice, Slovak Republic
2 Department of Medical and Clinical Biochemistry, Faculty of Medicine, Pavol Jozef ©afárik University in Ko¹ice, Ko¹ice, Slovak Republic

Background and Aim: Cardiovascular disease is a serious problem increasingly affecting young people worldwide. Cardio-metabolic risk factors include lipid profile parameters and atherogenic index of plasma (AIP), as well as basic anthropometric parameters such as the ratio of waist circumference to height (WHtR). The aim of our study was to determine WHtR.

Method: WHtR was determined in a group of 500 clinically healthy young people aged 18-25 and, on the basis of measured data, a reference range for WHtR was designed.

Results: The average WHtR value for the whole group was 0.45±0.06, with 0.46±0.06 for men, and 0.44±0.06 for women. WHtR values in respondents with all other parameters in normal range were from 0.41 to 0.52 for men and from 0.38 to 0.50 for women. Values are similar to those observed in other studies across diverse world populations. A positive correlation was observed between WHtR and atherogenic indices (AP1, AIP) uric acid levels and lipid profile parameters at p<0.001, with the exception of glucose and HDL. WHtR and HDL were negatively correlated at p<0.001.

Conclusion: As WHtR can be easily determined, it can be used as another cardio-metabolic risk factor.

Keywords: atherogenic parameters, cardio-metabolic risk, lipid profile, waist circumference to height ratio, young people

Received: January 24, 2014; Revised: February 18, 2016; Accepted: February 18, 2016; Published: June 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Hertelyová Z, Va¹ková J, Va¹ko L. Waist Circumference-to-Height Ratio Detected in a Convenient Sample of Young Slovak People with Increased Cardio-Metabolic Risk. Cent Eur J Public Health. 2016;24(2):95-102. doi: 10.21101/cejph.a4007. PubMed PMID: 27434238.
Download citation

References

  1. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and allcause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J. 2006 Jan;27(1):107-13. Go to original source... Go to PubMed...
  2. Müller-Nordhorn J, Binting S, Roll S, Willich SN.An update on regional variation in cardiovascular mortality within Europe. Eur Heart J. 2008 May;29(10):1316-26. Go to original source...
  3. Hujova Z, Lesniakova M.Anthropometric risk factors of atherosclerosis: differences between urban and rural East-Slovakian children and adolescents. Bratisl Lek Listy. 2011;112(9):491-6. Go to PubMed...
  4. Hujova Z, Rostakova K. Several anthropometric predictors of cardiovascular disease in central Slovakian adults: socioeconomic and educational differences. Bratisl Lek Listy. 2013;114(1):31-5. Go to original source... Go to PubMed...
  5. Grundy SM. Gamma-glutamyl transferase: another biomarker for metabolic syndrome and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):4-7. Go to original source... Go to PubMed...
  6. Gersch C, Palii SP, Imaram W, Kim KM, Karumanchi SA, Angerhofer A, et al. Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids. 2009 Feb;28(2):118-49. Go to original source... Go to PubMed...
  7. Sebo P, Beer-Borst S, Haller DM, Bovier PA. Reliability of doctors' anthropometric measurements to detect obesity. Prev Med. 2008 Oct;47(4):389-93. Go to original source... Go to PubMed...
  8. Mason C, Craig CL, Katzmarzyk PT. Influence of central and extremity circumferences on all-cause mortality in men and women. Obesity (Silver Spring). 2008 Dec;16(12):2690-5. Go to original source... Go to PubMed...
  9. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr. 2003 Feb;77(2):379-84. Go to original source... Go to PubMed...
  10. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012 Mar;13(3):275-86. Go to original source... Go to PubMed...
  11. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-toheight ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev. 2010 Dec;23(2):247-69. Go to original source... Go to PubMed...
  12. Jayawardana R, Ranasinghe P, Sheriff MH, Matthews DR, Katulanda P. Waist to height ratio: a better anthropometric marker of diabetes and cardio-metabolic risks in South Asian adults. Diabetes Res Clin Pract. 2013 Mar;99(3):292-9. Go to original source... Go to PubMed...
  13. Zeng Q, He Y, Dong S, Zhao X, Chen Z, Song Z, et al. Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults. Br J Nutr. 2014 Nov 28;112(10):1735-44. Go to original source... Go to PubMed...
  14. Zhu Q, Shen F, Ye T, Zhou Q, Deng H, Gu X. Waist-to-height ratio is an appropriate index for identifying cardiometabolic risk in Chinese individuals with normal body mass index and waist circumference. J Diabetes. 2014 Nov;6(6):527-34. Go to original source... Go to PubMed...
  15. Hertelyova Z, Salaj R, Chmelarova A, Dombrovsky P, Dvorakova MC, Kruzliak P. The association between lipid parameters and obesity in university students. J Endocrinol Invest. 2015 Jan 20. In Press. Go to original source...
  16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499-502. Go to original source...
  17. Dobiásová M. Atherogenic index of plasma [log(triglycerides/HDLcholesterol)]: theoretical and practical implications. Clin Chem. 2004 Jul;50(7):1113-5. Go to original source... Go to PubMed...
  18. Dobiásová M. AIP - atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006 Jan;52(1):64-71. (In Czech.) Go to PubMed...
  19. Cannon CP. Cardiovascular disease and modifiable cardiometabolic risk factors. Clin Cornerstone. 2007;8(3):11-28. Go to original source... Go to PubMed...
  20. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004 Jun 15;109(23 Suppl 1):III15-9. Go to original source...
  21. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421. Go to original source...
  22. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002 Jan 22;105(3):310-5. Go to original source...
  23. Cooney MT, Dudina A, De Bacquer D, Fitzgerald A, Conroy R, Sans S, et al.; SCORE Investigators. How much does HDLcholesterol add to risk estimation? A report from the SCORE Investigators. Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):304-14. Go to original source... Go to PubMed...
  24. Cooney MT, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, Menotti A, et al.; SCORE investigators. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis. 2009 Oct;206(2):611-6. Go to original source... Go to PubMed...
  25. Yarnell JW, Patterson CC, Sweetnam PM, Thomas HF, Bainton D, Elwood PC, et al. Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-up of Caerphilly and Speedwell Cohorts. Arterioscler Thromb Vasc Biol. 2001 Aug;21(8):1340-5. Go to original source... Go to PubMed...
  26. Welty FK. How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? Curr Cardiol Rep. 2013 Sep;15(9):400. doi: 10.1007/s11886-013-0400-4. Go to original source... Go to PubMed...
  27. Gómez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, AgudoConde C, Rodríguez-Sánchez E, Gómez-Sánchez L, et al.;Vasorisk group. Relationship between uric acid and vascular structure and function in hypertensive patients and sex-related differences.Am J Hypertens. 2013 May;26(5):599-607. Go to original source... Go to PubMed...
  28. GagliardiAC, Miname MH, Santos RD. Uric acid:Amarker of increased cardiovascular risk. Atherosclerosis. 2009 Jan;202(1):11-7. Go to original source... Go to PubMed...
  29. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013 Oct;62(10):3307-15. Go to original source... Go to PubMed...
  30. Lu W, Xu Y, Shao X, Gao F, Li Y, Hu J, et al. Uric Acid Produces an Inflammatory Response throughActivation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders. Sci Rep. 2015 Jul 16;5:12144. doi: 10.1038/srep12144. Go to original source... Go to PubMed...
  31. Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Memon L, ZeljkovicA, Bogavac-Stanojevic N, et al. High serum uric acid and lowgrade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis. 2009 Mar;203(1):236-42. Go to original source... Go to PubMed...
  32. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell. 2008 Oct 3;135(1):61-73. Go to original source... Go to PubMed...
  33. Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011 Apr;60(4):1258-69. Go to original source... Go to PubMed...
  34. Arruda AP, Milanski M, Coope A, Torsoni AS, Ropelle E, Carvalho DP, et al. Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion. Endocrinology. 2011 Apr;152(4):1314-26. Go to original source... Go to PubMed...
  35. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012 Mar;13(3):275-86. Go to original source... Go to PubMed...
  36. Després JP, Lemieux S, Lamarche B, Prud'homme D, Moorjani S, Brun LD, et al. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Int J Obes Relat Metab Disord. 1995 May;19 Suppl 1:S76-86.
  37. Jeong SK, Seo MW, Kim YH, Kweon SS, Nam HS. Does waist indicate dyslipidemia better than BMI in Korean adult population? J Korean Med Sci. 2005 Feb;20(1):7-12. Go to original source... Go to PubMed...